We estimate that the CEO of Krystal Biotech, Inc. ($KRYS), Krish S. Krishnan, received a compensation of $10,442,485 in 2025. This is a decrease of -49.42% from an estimated $15,603,652 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on April 03, 2026. Note that parsing errors may occur.
You can track $KRYS on Quiver Quantitative's $KRYS stock dashboard.
$KRYS Stock Insider Trading Activity
$KRYS Stock insiders have traded $KRYS stock on the open market 84 times in the past 6 months. Of those trades, 0 have been purchases and 84 have been sales.
Here’s a breakdown of recent trading of $KRYS stock by insiders over the last 6 months:
- DANIEL JANNEY has made 0 purchases and 22 sales selling 71,964 shares for an estimated $19,402,207.
- SUMA KRISHNAN (President, R&D) has made 0 purchases and 26 sales selling 75,000 shares for an estimated $17,587,603.
- KRISH S KRISHNAN (President and CEO) has made 0 purchases and 26 sales selling 75,000 shares for an estimated $17,586,611.
- DINO A ROSSI has made 0 purchases and 2 sales selling 18,950 shares for an estimated $4,953,694.
- KATHRYN ROMANO (Chief Accounting Officer) has made 0 purchases and 8 sales selling 13,250 shares for an estimated $3,602,405.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$KRYS Stock Hedge Fund Activity
We have seen 173 institutional investors add shares of $KRYS Stock stock to their portfolio, and 135 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 776,739 shares (-95.9%) from their portfolio in Q4 2025, for an estimated $191,497,233
- BELLEVUE GROUP AG added 409,011 shares (+31174.6%) to their portfolio in Q4 2025, for an estimated $100,837,571
- BRAIDWELL LP removed 318,300 shares (-61.2%) from their portfolio in Q4 2025, for an estimated $78,473,682
- CITADEL ADVISORS LLC removed 250,483 shares (-39.3%) from their portfolio in Q4 2025, for an estimated $61,754,078
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 227,038 shares (+152.1%) to their portfolio in Q4 2025, for an estimated $55,973,948
- JANUS HENDERSON GROUP PLC added 209,369 shares (+2078.9%) to their portfolio in Q4 2025, for an estimated $51,617,833
- FRAZIER LIFE SCIENCES MANAGEMENT, L.P. removed 200,000 shares (-29.1%) from their portfolio in Q4 2025, for an estimated $49,308,000
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$KRYS Stock Analyst Ratings
Wall Street analysts have issued reports on $KRYS in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Buy" rating on 01/22/2026
- Citigroup issued a "Buy" rating on 01/12/2026
- HC Wainwright & Co. issued a "Buy" rating on 01/09/2026
To track analyst ratings and price targets for $KRYS Stock, check out Quiver Quantitative's $KRYS forecast page.
$KRYS Stock Price Targets
Multiple analysts have issued price targets for $KRYS recently. We have seen 8 analysts offer price targets for $KRYS in the last 6 months, with a median target of $320.5.
Here are some recent targets:
- Debjit Chattopadhyay from Guggenheim set a target price of $284.0 on 02/25/2026
- Geulah Livshits from Chardan Capital set a target price of $323.0 on 02/18/2026
- Yigal Nochomovitz from Citigroup set a target price of $371.0 on 02/18/2026
- Roger Song from Jefferies set a target price of $371.0 on 02/17/2026
- Andrea Tan from Goldman Sachs set a target price of $327.0 on 02/02/2026
- Alec Stranahan from B of A Securities set a target price of $318.0 on 01/22/2026
- Joseph Pantginis from HC Wainwright & Co. set a target price of $310.0 on 01/09/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
